Participation of the opioid system in cannabinoid-induced antinociception and emotional-like responses.
Several anatomical, biochemical and pharmacological evidence support the existence of bidirectional interactions between cannabinoid and opioid systems. The present review is focused on the participation of the endogenous opioid system in the antinociceptive and emotional-like responses induced by cannabinoids, and the development of tolerance to cannabinoid pharmacological effects. Cannabinoid and opioid agonists produce antinociception by acting on similar structures within the central nervous system, and a peripheral mechanism has been also proposed for both compounds. Pharmacological studies have suggested that the endogenous opioid system could be involved in cannabinoid antinociception and the development of cannabinoid tolerance. Recent studies using knockout mice have also demonstrated the role of the opioid system in cannabinoid antinociception and tolerance, although some discrepancies with the previous pharmacological results have been reported when using knockout mice. On the other hand, cannabinoid administration can induce anxiolytic-like responses that are mediated at least in part by an endogenous opioid activity on micro- and delta-opioid receptors.
Maldonado
Rafael
R
Laboratori de Neurofarmacologia, Departament de Ciènces Experimentals i de la Salut, Universitat Pompeu Fabra, C/Doctor Aiguader, s/n. 08003, Barcelona, Spain. rafael.maldonado@upf.edu
Valverde
Olga
O
D000700:Analgesics / Q000494:pharmacology*; D000818:Animals; D002186:Cannabinoids / Q000494:pharmacology*; D004361:Drug Tolerance; D004644:Emotions / Q000187:drug effects*; D006801:Humans; D051379:Mice; D018345:Mice, Knockout; D009294:Narcotics / Q000494:pharmacology*; D051381:Rats; D011957:Receptors, Opioid / Q000378:metabolism*
D000700:Analgesics; D002186:Cannabinoids; D009294:Narcotics; D011957:Receptors, Opioid